About us

We are driven to develop meaningful therapies for patients while creating value for stockholders.

Aspargo Labs develops patient-focused solutions and must-have medicines by utilizing our proprietary technology to enhance previously approved drugs with well-known pharmacology profiles.

Our initial product candidate is a proprietary oral suspension formulation of sildenafil citrate, the active ingredient in VIAGRA®.

We believe no one else has the trade secrets or expertise to do what we do.

Aspargo Labs comprised of veterans in the specialty pharma and biotech industries, with decades of experience in developing and marketing disruptive therapeutic agents, preparing and submitting FDA and EMA regulatory submissions and obtaining drug approvals in the United States and abroad.

Michael Demurjian
Chairman and Chief Executive Officer READ bio
Robert Niecestro, PhD
Executive Vice President Research and Development READ bio
Steven Kaplan, MD
Medical Advisory Board READ bio

We believe our experience with
ED spray will give rise to countless other opportunities.

To find out more about Aspargo Labs, send us a message.

This field is for validation purposes and should be left unchanged.